binimetinib and Craniopharyngioma

binimetinib has been researched along with Craniopharyngioma* in 1 studies

1 other study(ies) available for binimetinib and Craniopharyngioma

Article	Year
Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma. Pediatric blood & cancer, 2021, Volume: 68, Issue:3 Topics: Adult; Benzimidazoles; Craniopharyngioma; Female; Humans; Magnetic Resonance Imaging; MAP Kinase Kinase 1; Pituitary Neoplasms; Protein Kinase Inhibitors; Wnt1 Protein	2021